1Li W, Wang Y, Han Z, et al. Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese pa- tient with lipoprotein glomerulopathy[J]. Kidney Blood Press Res,2014,39(4) :330-339.
2Boumendjel R, Papari M, Gonzalez M. A rare case of lipopro- tein glomerulopathy in a white man:an emerging entity in A- sia,rare in the white population[J]. Arch Pathol Lab Med, 010,134(2) : 279-282.
3Saito T, Matsunaga A. Lipoprotein glomerulopathy may pro- vide a key to unlock the puzzles of renal lipidosis[J]. Kindey Int,2014,85(2) :243-245.
4Oiawa S,Suzuki N, Sakuma E, et al. Abnormal lipoprotein and apolipopro-tein pattern in lipoprotein glomerulopathy[J]. Am J Kidney Dis,1991,18(5) :553-558.
5Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sen- dai (arginine 145--proline): a new variant associated with lipoprotein glomerulopathy [J ]. J Am Soc Nephrol, 1997, 8 (5) :820-823.
6Foster K, Matsunaga A, Matalon R, et al. A rare cause of post- transplantation nephrotic syndrome [J]. Am J Kidney Dis, 2005,45(6) : 1132-1138.
8Ogawa T, Maruyama K, Hattori H, et al. Anewvariant of apoli- popro-tein E(apo E Maebashi) in lipoprotein glomerulopathy[J]. PediatrNephrol, 2000,14 (2) : 149-151.
9Russi G, Furci L, Leonelli M, et al. Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-indueed Extracorporeal Lip- oprotein Precipitation system) : a case report [J]. J Med Case Re- ports,2009,3:9311.
10Bomback A S,Song H,D'Agati V D,et al. A new apolipopro- tein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy [J]. Nephrol Dial Trans plant,2010,25(10) :3442-3446.
7[8]Wen M, Segerer S, Dantas M,et al. Renal injury in Apolipoprotein E-Deficient mice. Lab Invest, 2002 ,82:999
8[12]Li LS, Liu ZH, Ji DX,et al. Novel effective treatment of lipoprotein glomerulopathy-immunoadsorption onto protein A. J Am Soc Nephrol, 2001,12:A0592
9[13]Ieiri N, Hotta O, Taguma Y. Resolution of typical lipoprotein glomerulopathy by intensive lipid-lowering therapy. Am J Kidney Dis, 2003,41:244
10[14]Arai T, Yamashita S, Yamane M,et al. Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotic syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy. Atherosclerosis, 2003,169: 293
